When combined, the two cohorts produced a highly significant discrimination between cancer patients and controls for all investigated miRNAs, with the strongest discrimination achieved by miR-652 and miR-148b (Additional file 1 : Figure S1).
← all excerpts
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
1
—
—